Home / VOL 1 / Issue 1 / Case Study

mRNA Vaccines: Beyond COVID-19

The Future of Vaccine Development

Published Jul 28, 2025

0 downloads

0 citations

mRNA vaccines immunology lipid nanoparticles

Issue: Issue 1 (Vol. VOL 1)

DOI: https://doi.org/2n0292172342987211

Authors

KAVITA A

Department of Gastroenterology, Guntur Medical College and Government General Hospital, Guntur, Andhra Pradesh, India.

Abstract

mRNA vaccines, popularized by COVID-19 vaccines like Pfizer-BioNTech, encode antigens to trigger immune responses. Their flexibility allows rapid development for diseases like influenza, Zika, and cancer. Lipid nanoparticles protect mRNA and enhance delivery to cells.

Challenges include storage requirements (e.g., ultra-cold temperatures) and scalability. Research focuses on thermostable formulations and applications in personalized cancer vaccines. mRNA technology also shows promise in protein replacement therapies.

Stats

Views Statistics

Downloads Statistics

Download & Share

See PDF Download PDF

Article Details

DOI:

https://doi.org/2n0292172342987211

Status:

published

How To Cite?

KAVITA A, et al. "mRNA Vaccines: Beyond COVID-19".

OpenJournal system, VOL 1, Issue 1, Case Study.

DOI: https://doi.org/2n0292172342987211